大動脈ステントグラフト市場規模、シェア、成長分析：製品別、エンドユーザー別、地域別 - 産業予測 2025～2032年

大動脈ステントグラフトの世界市場規模は2023年に32億米ドルと評価され、予測期間（2025-2032年）のCAGRは4.7%で、2024年の33億5,000万米ドルから2032年には48億4,000万米ドルに成長する見通しです。

世界の大動脈ステントグラフト市場は、主に心血管疾患の増加と平均寿命の延長に関連した大動脈瘤の有病率の増加によって、顕著な成長が見込まれています。患者やヘルスケアプロバイダーが従来の手術よりも血管内修復術を好むようになり、回復が早く不快感が少ない低侵襲手術の需要が急増しています。その要因としては、都市化、ヘルスケアインフラの進歩、ステント設計の改善を目指した研究開発の進行などが挙げられます。しかし、新しい血管内動脈瘤修復術（EVAR）治療に対する認知度の低さ、エンドリークのような合併症のリスク、医療が行き届いていない地域における熟練した医療従事者の不足といった課題に直面しています。市場の潜在力を最大限に引き出すには、こうしたハードルに対処することが重要です。

目次

イントロダクション

• 調査の目的
• 調査範囲
• 定義

調査手法

• 情報調達
• 二次と一次データの方法
• 市場規模予測
• 市場の前提条件と制限

エグゼクティブサマリー

• 世界市場の見通し
• 供給と需要の動向分析
• セグメント別機会分析

市場力学と見通し

• 市場概要
• 市場規模
• 市場力学
  • 促進要因と機会
  • 抑制要因と課題
• ポーターの分析

主な市場の考察

• 重要成功要因
• 競合の程度
• 主な投資機会
• 市場エコシステム
• 市場の魅力指数（2024年）
• PESTEL分析
• マクロ経済指標
• バリューチェーン分析
• 価格分析

大動脈ステントグラフト市場規模：製品別& CAGR（2025-2032）

• 市場概要
• 腹部大動脈ステントグラフト
• 胸部大動脈ステントグラフト

大動脈ステントグラフト市場規模：エンドユーザー別& CAGR（2025-2032）

• 市場概要
• 病院
• 外来手術センター

大動脈ステントグラフト市場規模：地域別& CAGR（2025-2032）

• 北米
  • 米国
  • カナダ
• 欧州
  • ドイツ
  • スペイン
  • フランス
  • 英国
  • イタリア
  • その他欧州地域
• アジア太平洋地域
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋地域
• ラテンアメリカ
  • ブラジル
  • その他ラテンアメリカ地域
• 中東・アフリカ
  • GCC諸国
  • 南アフリカ
  • その他中東・アフリカ

競合情報

• 上位5社の比較
• 主要企業の市場ポジショニング（2024年）
• 主な市場企業が採用した戦略
• 最近の市場動向
• 企業の市場シェア分析（2024年）
• 主要企業の企業プロファイル
  • 企業の詳細
  • 製品ポートフォリオ分析
  • 企業のセグメント別シェア分析
  • 収益の前年比比較（2022-2024）

主要企業プロファイル

• Medtronic（Ireland）
• W. L. Gore & Associates, Inc.（USA）
• Cook Medical（USA）
• Terumo Aortic（Japan）
• Endologix LLC（USA）
• Jotec（Germany）
• MicroPort Scientific Corporation（China）
• Corcym（Italy）
• Edwards Lifesciences Corporation（USA）
• Bentley Healthcare Pvt. Ltd.（India）
• Braile Biomedica（Brazil）
• Cardinal Health（USA）
• InSitu Technologies Inc.（USA）
• Artivion Inc.（USA）
• Cryolife Inc.（USA）
• Lombard Medical Inc.（UK）
• Bolton Medical（Spain）

結論と提言

Global Aortic Stent Grafts Market size was valued at USD 3.2 billion in 2023 and is poised to grow from USD 3.35 billion in 2024 to USD 4.84 billion by 2032, growing at a CAGR of 4.7% during the forecast period (2025-2032).

The global aortic stent graft market is poised for notable growth, primarily driven by an increasing prevalence of aortic aneurysms linked to rising cardiovascular diseases and longer life expectancies. As patients and healthcare providers favor endovascular repairs over traditional surgeries, there is a surge in demand for minimally invasive procedures that offer quicker recovery times and reduced discomfort. Contributing factors include urbanization, advancements in healthcare infrastructure, and ongoing research and development targeting improved stent designs. However, market growth faces challenges such as limited awareness of new endovascular aneurysm repair (EVAR) treatments, risks of complications like endoleaks, and a shortage of skilled medical professionals in underserved regions. Addressing these hurdles will be critical for maximizing the market's potential.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Aortic Stent Grafts market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Aortic Stent Grafts Market Segments Analysis

Global Aortic Stent Grafts Market is segmented by Product, End User and region. Based on Product, the market is segmented into Abdominal Aortic Stent Graft and Thoracic Aortic Stent Graft. Based on End User, the market is segmented into Hospitals and Ambulatory Surgical Centers. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Aortic Stent Grafts Market

The global aortic stent grafts market is expected to experience significant growth throughout the forecast period, driven by several key factors. The preference for endovascular repair techniques over traditional open surgical methods is gaining momentum, alongside rising life expectancy rates. Additionally, the increasing adoption of minimally invasive surgical procedures contributes to this trend. The surge in clinical trials and FDA approvals aimed at developing innovative aortic stent graft designs further propels market expansion. As these elements align, they collectively enhance the demand for aortic stent grafts, positioning the market for promising advancements and opportunities in the years ahead.

Restraints in the Global Aortic Stent Grafts Market

However, the growth of the Global Aortic Stent Grafts market may be hindered by several factors, including a shortage of properly trained healthcare professionals and insufficient knowledge regarding the new Endovascular Aneurysm Repair (EVAR) techniques. Additionally, concerns about potential complications, such as endoleaks and other risks associated with aortic stent grafts, could further limit market development during the forecast period. These challenges may impact the adoption and implementation of advanced treatments in various healthcare settings, ultimately affecting the overall market dynamics for aortic stent grafts.

Market Trends of the Global Aortic Stent Grafts Market

The Global Aortic Stent Grafts market is poised for significant growth from 2023 to 2030, driven by an ageing demographic and a rising incidence of aortic aneurysms. As the prevalence of cardiovascular diseases increases, coupled with heightened awareness regarding stenting and grafting technologies, demand for these medical devices is expected to burgeon. Additionally, the landscape is being positively influenced by a surge in regulatory approvals and rapid advancements in medical technology, which enhance the efficacy and safety of stent grafts. Collectively, these factors are shaping a robust market trend, positioning aortic stent grafts as critical components in cardiovascular healthcare solutions.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Aortic Stent Grafts Market Size by Product & CAGR (2025-2032)

• Market Overview
• Abdominal Aortic Stent Graft
• Thoracic Aortic Stent Graft

Global Aortic Stent Grafts Market Size by End User & CAGR (2025-2032)

• Market Overview
• Hospitals
• Ambulatory Surgical Centers

Global Aortic Stent Grafts Market Size & CAGR (2025-2032)

• North America (Product, End User)
  • US
  • Canada
• Europe (Product, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Medtronic (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• W. L. Gore & Associates, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cook Medical (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Terumo Aortic (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Endologix LLC (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Jotec (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MicroPort Scientific Corporation (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Corcym (Italy)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Edwards Lifesciences Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bentley Healthcare Pvt. Ltd. (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Braile Biomedica (Brazil)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cardinal Health (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• InSitu Technologies Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Artivion Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cryolife Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lombard Medical Inc. (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bolton Medical (Spain)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations